Analysts’ Opinions Are Mixed on These Consumer Cyclical Stocks: DraftKings (DKNG), Bath & Body Works (BBWI) and Intercontinental Hotels Group (IHG)
Companies in the Consumer Cyclical sector have received a lot of coverage today as analysts weigh in on DraftKings (DKNG – Research Report), Bath & Body Works (BBWI – Research Report) and Intercontinental Hotels Group (IHG – Research Report).
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
DraftKings (DKNG)
Jefferies analyst David Katz reiterated a Buy rating on DraftKings today and set a price target of $46.00. The company’s shares closed last Friday at $21.76.
According to TipRanks.com, Katz is a 4-star analyst with an average return of
DraftKings has an analyst consensus of Strong Buy, with a price target consensus of $37.37, representing a 73.4% upside. In a report issued on February 2, Canaccord Genuity also maintained a Buy rating on the stock with a $50.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Bath & Body Works (BBWI)
Goldman Sachs analyst Kate McShane maintained a Hold rating on Bath & Body Works today. The company’s shares closed last Friday at $24.07.
According to TipRanks.com, McShane is a 4-star analyst with an average return of
The word on The Street in general, suggests a Hold analyst consensus rating for Bath & Body Works with a $21.25 average price target, which is a -8.1% downside from current levels. In a report released today, Citi also downgraded the stock to Hold with a $25.00 price target.
Intercontinental Hotels Group (IHG)
Jefferies analyst Simon LeChipre maintained a Buy rating on Intercontinental Hotels Group today and set a price target of $160.00. The company’s shares closed last Friday at $146.13.
According to TipRanks.com, LeChipre is ranked #7184 out of 12109 analysts.
Intercontinental Hotels Group has an analyst consensus of Moderate Buy, with a price target consensus of $153.14, implying a 3.1% upside from current levels. In a report issued on February 11, Barclays also maintained a Buy rating on the stock with a $155.00 price target.
